← Evidence map

ReviewPharmaceutics2022

Developments in Combining Targeted Radionuclide Therapies and Immunotherapies for Cancer Treatment.

Caroline P Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

30 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36678756